Comparing serology, antigenemia assay and polymerase chain reaction for the diagnosis of cytomegalovirus infection in renal transplant patients

Journal of Association of Physicians of India

Volumn 52, Issue APR, 2004, Pages 297-300

  Bhatia, Jigna ^a   Shah, B V ^a   Mehta, Ajita P ^a   Deshmukh, Minal ^a   Sirsat, Rasika A ^a   Rodrigues, Camilla ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; FEMALE; GENETICS; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTION AND FORECASTING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ADOLESCENT; ADULT; ANTIGENS, VIRAL; CASE-CONTROL STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 13744254770     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Marcille BMI, Cantarovich D, Aubineau VF, Richet B, Soulillou JP, Billaudel S. Usefulness of DNA viral load quantification for CMV disease monitoring in renal and pancreas transplant recipients. Transplantation 1997;63:1476-81.
2. Caliendo AM, George SK, Kao SY, Allega J, Tan BH, Fontaine RL, Bui L, Rinaldo CR. Comparison of quantitative CMV PCR in plasma and CMV Antigenemia assay: Clinical utility of the prototype Amplicor CMV monitor test in transplant recipients. J Clin Microbiol 2000;2122-27.
3. Marmol SBL, Greene JN, Sandin LR. Capturing CMV in blood specimens with a new amplification assay. Infect Med 2001;18:209-11.
4. Sia GI, Patel R. New strategies for processing for prevention and therapy of CMV infection and disease in solid organ transplant recipients. Clin Microbiol Rev 2000;13:83-121.
5. Amorim ML, Cabeda JM, Sera R, Mendes AC, Castro AP, Amorim JM. CMV infection of liver transplant recipients? Comparison of antigenemia and molecular biology assays. BMC Infectious diseases 2001;1-2:1471-2334.
6. Barber L, Egan JJ, Lomex J, Yonan N, Derianiya AK, Turner AJ, Woodcock AA et al. Comparative study of three PCR assays with antigenemia and serology for the diagnosis of HCMV infection in thoracic transplant recipients. J Med Virol 1996;49:137-44.
7. Levy R, Najaioullah F, Thovenot D, Bosshard S, Aymard M, Lina B. Evaluation and comparison of PCR and hybridization methods for rapid detection of CMV in clinical samples. J Virol Method 1995;60:103-11.
8. Rao M, Finny GJ, Abraham P, Juneja R, Thomas PP, Jacob CK, Sridharan G. CMV infection in a seroendemic renal transplant population: A longitudinal study of virological markers. Nephron 2000;84:367-73.
9. Heemann U, Wenzel RR. CMV prophylaxis! What is valid in 2002? Nephrol Dial Transplant 2002;17:556-59.
10. Flechner SM, Avery RR, Fisher R, Mastroianni B, Papajcik D, Malley KJ, Goormastic M et al. Monitoring of CMV infection after Renal transplantation serology, culture, and viral DNA detection by hybrid capture. Transplant Proc 1999;37:1255-57.
11. Prieser W, Brauninger S, Schwerdtfeger R, Ayliffe U, Garson JA, Brink NS, Franck S. et al. Evaluation of diagnostic methods from the detection of CMV in recipients of allogenic stem cell transplants. J Clin Virol 2001;20:59-70.
12. Tanabe K, Tokumoto T, Ishikawa I, Kayama I, Takahashi K, Fuchinoue S, Kawai T et al. Comparative study of CMV antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation 1997;64:1721-25.
13. Eckart P, Brouard J, Vabert A, Freymuth F, Guillot M, Ryckelynck JP, Hurault de Ligny. Detection of human cytomegalovirus in renal transplantation: comparison of four diagnostic methods: DNA in sera by polymerase chain reaction (PCR), DNA in leukocytes by PCR, pp65 antigenemia, and viremia. Transplant Proc1997;29:2387-89.
14. Landry ML, Ferguson D, Cohen S, Huber K, Wetherill P. Effect of delayed specimen processing on cytomegalovirus antigenemia test results. J Clin Microbiol 1995;33:257-59.
15. Gerna G, Furione M, Baldanti F, Sarasini A. Comparative quantitation of human CMV DNA in blood leukocytes and plasma of transplant and AIDS patients. J Clin Microbiol 1994;32:2709-17.
16. Boeckh M, Gallez-Haurkias GM, Myerson D, Zaia J, Bowden RA. Plasma polymerase chain reaction for CMV DNA after allogenic bone marrow transplantation. Transplantation 1997;84:108-13.
17. Roberts TC, Brenan DC, Buller RS, Gaundreault Keener M, Schnitzler MA, Sternhell KE. Quantitative polymerase chain reaction to predict occurrence of symptomatic CMV infection and assess response to gancyclovir therapy in renal transplant recipients. J Infect Dis 1998;178:626-35.
18. Abecasis MN, Koffron AJ, Kaplan B, Burkingham M, Muldoon JP, Gibbins AJ, Kaufman DB et al. The role of PCR in the diagnosis and management of CMV in solid organ transplant recipients. Transplantation 1997;63:275-79.
19. Kanj SS, Sharara AI, Clavien PA, Hamilton JD .CMV infection following liver transplantation: Review of the Literature. Clin Infect Dis 1996;22:537-49.